positive regulation of RNA splicing

Definition

Target type: biologicalprocess

Any process that activates or increases the frequency, rate or extent of RNA splicing. [GOC:mah]

Positive regulation of RNA splicing is a complex process that ensures the precise removal of introns and the joining of exons during gene expression. This intricate process is crucial for generating diverse protein isoforms from a single gene, thereby expanding the proteome and enabling cellular adaptation. The process is tightly regulated by a variety of factors, including:

1. **Spliceosome Assembly and Function:** The spliceosome, a dynamic ribonucleoprotein complex, is the primary machinery responsible for intron removal. Its assembly is a multi-step process involving the sequential recruitment of small nuclear ribonucleoprotein particles (snRNPs) and other splicing factors to the pre-mRNA. These factors bind to specific sequences within the pre-mRNA, known as splice sites, and facilitate the proper recognition and excision of introns.

2. **Cis-acting Regulatory Elements:** The pre-mRNA itself contains cis-acting regulatory elements that influence splicing decisions. These elements include:

- **Splice sites:** The 5' and 3' splice sites define the boundaries of the intron. Mutations in these sites can disrupt splicing and lead to disease.
- **Branch point sequence:** Located within the intron, the branch point sequence is crucial for lariat formation, a key step in intron removal.
- **Exonic splicing enhancers (ESEs):** These sequences promote the inclusion of specific exons in the mature mRNA.
- **Intronic splicing enhancers (ISEs):** Similar to ESEs, these elements enhance the inclusion of exons.
- **Exonic splicing silencers (ESSs):** These sequences repress the inclusion of specific exons.
- **Intronic splicing silencers (ISSs):** Like ESSs, these elements promote the exclusion of exons.

3. **Trans-acting Regulatory Factors:** A diverse array of trans-acting factors, including RNA-binding proteins and enzymes, modulate splicing decisions by interacting with cis-acting elements. These factors can:

- **Promote splicing:** Factors that bind to ESEs and ISEs promote the inclusion of exons.
- **Repress splicing:** Factors that bind to ESSs and ISSs promote the exclusion of exons.
- **Alter splicing patterns:** Some factors can modulate the recognition of splice sites, leading to alternative splicing outcomes.

4. **Chromatin Structure and Modifications:** The accessibility of pre-mRNA to splicing factors is influenced by chromatin structure and modifications. For instance, histone modifications can regulate the recruitment of splicing factors to specific genes.

5. **Post-transcriptional Regulation:** Splicing can be influenced by post-transcriptional events, including:

- **Nuclear export:** The export of pre-mRNA from the nucleus can be regulated, affecting the availability of transcripts for splicing.
- **mRNA stability:** The stability of pre-mRNA can influence the efficiency of splicing.

**Positive regulation of RNA splicing involves the enhancement of the splicing process, leading to increased inclusion of specific exons or the overall efficiency of intron removal. This can occur through:**

- **Increased recruitment of splicing factors:** Positive regulators can promote the assembly of the spliceosome and enhance the binding of splicing factors to specific splice sites or regulatory elements.
- **Activation of splicing factors:** Some positive regulators can directly activate the activity of splicing factors, enhancing their ability to promote splicing.
- **Modification of chromatin structure:** Positive regulators can promote chromatin modifications that enhance the accessibility of pre-mRNA to splicing factors.
- **Regulation of pre-mRNA export:** Positive regulators can enhance the export of pre-mRNA from the nucleus, increasing the availability of transcripts for splicing.

Understanding the intricate regulatory mechanisms of positive regulation of RNA splicing is crucial for deciphering the complexities of gene expression and the development of novel therapeutic strategies for diseases linked to splicing defects.'
"

Proteins (6)

Compounds (337)